PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New lung cancer guidelines recommends offering screening to high-risk individuals

Advances in treatment have major impact on short- and long-term outcomes

2013-05-07
(Press-News.org) (NORTHBROOK, IL, MAY 7, 2013) –The American College of Chest Physicians (ACCP) third edition of evidence-based lung cancer guidelines, Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, recommends offering low-dose computed tomography (LDCT) scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history.

Published as a special supplement to the May issue of CHEST, ACCP's peer-reviewed journal, the guidelines cite evidence to show lung cancer screening, through a structured and specific protocol, can reduce lung cancer deaths among individuals who are at elevated risk of developing lung cancer. The guidelines also document the advances made over the past 5 years in the treatment of tobacco use, including the benefits of tobacco cessation programs, in patients with lung cancer. The most effective deterrent to acquiring lung cancer is avoidance of tobacco products.

"Our new lung cancer guidelines take into account the many advances and new information in the field by providing comprehensive and nuanced recommendations related to prevention, screening, diagnosis, staging, and medical and surgical treatments," said Guideline Panel Chair, W. Michael Alberts, MD, MBA, FCCP, Moffitt Cancer Center, Tampa, FL. "It also showcases the importance of multidisciplinary, team-based care when it comes to effective lung cancer treatment—collaborative decisions based on collective knowledge provide the most comprehensive patient-focused care."

SCREENING

For individuals at elevated risk of developing lung cancer, the guidelines recommend offering LDCT scanning to screen for lung cancer in the context of a structured, organized screening program. The recommendation is based on a systematic review of the data that shows an important reduction in deaths from lung cancer when screening is done in an organized program. This is a clear change from the prior edition of the guidelines released in 2007, when such evidence was not available.

Lung cancer screening is a complex interplay of an individual's risk and many other key factors, including how LDCT scanning is performed and interpreted by the team. This must then be coupled with careful judgment that minimizes interventions to those that are necessary and education to appropriately balance concerns associated with lung cancer, radiation, and observation of incidental nodules. The guidelines call for the establishment of a registry designed to help address the large number of unanswered questions that arise as screening is implemented, as well as to clarify frequent misconceptions around lung cancer screening among patients and physicians. Additionally, the guidelines call for establishment of quality metrics so that benefits are optimized, and harm is kept low.

"Lung cancer screening offers a potential benefit for select individuals, but it is not a substitute for stopping smoking," said Frank Detterbeck, MD, FCCP, Yale University, New Haven, CT, and Vice-Chair of the Guidelines Panel. "However, screening is not a scan, it is a process. We have much to learn as we embark upon implementation of screening. Education on screening is the key to overcoming misconceptions and misguided fears. The guidelines include recommendations that help the patient and physician with the decision process. It provides a structure that gives a clearer interpretation of what we know and what we can only speculate."

ADVANCES IN TREATMENT

Treatment of lung cancer is progressing rapidly, with significant advances in all modalities, including surgery, radiation, and chemotherapy. Treatment procedures detailed in the guidelines include the benefits of minimally invasive surgery whenever possible, as well as the benefit of treatment at specialized centers. Today, patients with limited lung function also have treatment options such as stereotactic body radiosurgery, which is similar to using a GPS system to deliver a laser-accurate strike to a tumor. Molecular-based targeted chemotherapy can also shut down the cellular engine driving a tumor's growth as dramatically as flipping a switch. The guidelines also make it clear that a sophisticated approach to symptom control and palliative care can markedly improve both quality and quantity of life for individuals with lung cancer.

However, the data presented in the guidelines also underscore the importance of an integrated collaborative team of individuals, each with lung cancer expertise within his or her own specialty.

"All stages of non-small cell lung cancer involve complex factors," said Darcy Marciniuk, MD, FCCP, Royal University Hospital, Saskatoon, Saskatchewan, and ACCP President. "In the guidelines, we highlight these factors throughout all stages, including symptom management, special treatment, complementary or alternative therapies, and end-of-life care."

TREATMENT OF TOBACCO USE

An ounce of prevention is still best; and the science behind treatment of tobacco dependency has matured tremendously. This edition of the guidelines outlines how to select the right interventions for someone who smokes and improve the rate of successful abstinence from smoking.

"Smoking is a difficult addiction to overcome; however, significant advances have increased our understanding of the physiological and biological changes that make this chronic medical condition so challenging. Today, we have multiple treatment options to help these patients," said Frank Leone, MD, FCCP, University of Pennsylvania, Philadelphia, PA, and topic editor of "Treatment of Tobacco Use in Lung Cancer," in Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. "The guidelines include a detailed summary of the scientific basis and management strategies for an up-to-date, sophisticated, and evidence-based treatment program for tobacco use."

SYMPTOM MANAGEMENT AND PALLIATION

For patients with advanced lung cancer, a major concern is palliation, easing the severity of pain and symptoms. In the past, the approach to palliative care was largely empiric, but as summarized in the guidelines, a large body of research has led to the development of a more formal evidence-based process. Many tools are available that provide an effective structure for both symptom management and for facilitating the process of end-of-life care. The data also demonstrate that early inclusion of a palliative care team in the management of advanced lung cancer has meaningful quality of life benefits for the patient.

"The scope of this chapter is very large," said Michael J. Simoff, MD, FCCP, Henry Ford Hospital, Detroit, MI, and topic editor of "Symptom Management in Patients With Lung Cancer," in Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. "Few classic double-blind, randomized studies exist to give guidance in many of the areas covered in the chapter. Experts in many specialties were brought together to ask the questions necessary and get the best answers possible from the literature to guide physician management of the symptoms encountered in lung cancer patients."

The guidelines also devote attention to complementary therapies and integrative medicine in lung cancer. This includes interventions such as acupuncture, nutrition, and mind-body therapies. The guidelines outline which treatments and situations are scientifically supported for integration with standard treatments for lung cancer.



INFORMATION:

Methodology

The ACCP is at the forefront of defining the methodologic science of guideline development. The lung cancer guidelines are distinguished by this methodologic rigor and is a body of work that is as evidence-based, unbiased, and scientifically accurate as possible. The process involved thousands of hours and systematic reviews of the available data, conducted by over 100 expert panel members, including pulmonologists, medical oncologists, radiation oncologists, thoracic surgeons, integrative medicine specialists, oncology nurses, pathologists, health-care researchers, and epidemiologists, as well as trained methodologists. The guidelines were further reviewed and approved by the ACCP Thoracic Oncology NetWork, the Guidelines Oversight Committee, the ACCP Board of Regents, and external reviewers from the journal CHEST. The guidelines have been endorsed by the European Society of Thoracic Surgeons, Oncology Nursing Society, American Association for Bronchology and Interventional Pulmonology, and The Society of Thoracic Surgeons.

About Lung Cancer in the United States

Lung cancer continues to be the leading cause of cancer deaths in men and women in the United States and across the world, causing more deaths than the next four most common cancers combined, including colon, breast, pancreas, and prostate. Deaths from lung cancer in women surpassed those due to breast cancer in 1987. Declining rates of smoking have slowly reduced the rates of lung cancer, and the majority of those diagnosed with this disease today successfully quit smoking years earlier. Nevertheless, lung cancer remains a common cancer, even in lifelong never-smokers.

About CHEST and The American College of Chest Physicians

CHEST is a peer-reviewed journal published by the ACCP. It is available online each month at http://journal.publications.chestnet.org/. The ACCP is a global community of clinicians and allied health professionals working in pulmonary, critical care, and sleep medicine. The ACCP is recognized as a resource for advanced training through simulation education, conferences, and innovative courses. Headquartered in Northbrook, IL, the ACCP represents more than 18,700 members from more than 100 countries.

Contact:

Amy Friess, (202) 540-2371
afriess@lipmanhearne.com

Kristi Bruno, (847) 498-8308
kbruno@chestnest.org



ELSE PRESS RELEASES FROM THIS DATE:

Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms

2013-05-07
An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal congestion and itchy eyes experienced by ragweed allergy sufferers. Tests showed that treatment with the pill, which contains the protein Ambrosia artemisiifolia major allergen 1, and is placed under the tongue to be absorbed, also reduced the need for anti-allergy drugs to get relief. More than 80 million Americans are allergic to ragweed. The ...

Silk and cellulose biologically effective for use in stem cell cartilage repair

2013-05-07
Over 20 million people in Europe suffer from osteoarthritis which can lead to extensive damage to the knee and hip cartilage. Stem cells offer a promising way forward but a key challenge has been to design a 'smart material' that is biologically effective for cartilage tissue regeneration. Now researchers have identified a blend of naturally occurring fibres such as cellulose and silk that makes progress towards affordable and effective cell-based therapy for cartilage repair a step closer. The EPSRC-funded study, published in Biomacromolecules and undertaken by University ...

Do bats know voices of friends they hang out with?

2013-05-07
VIDEO: A bat reacts to contact call stimulus with a turning to the loudspeaker, placed on the right side. Click here for more information. Is it possible that mammals have the ability to recognize individuals of the same species, whom they know well, by their voice? A new study has found that even in nocturnal, fast-moving animals such as bats, there is an ability to recognize certain vocal aspects of other bats from their social groups. The study by Hanna Kastein from the University ...

All hospitals should require drug, alcohol tests for physicians

2013-05-07
To improve patient safety, hospitals should randomly test physicians for drug and alcohol use in much the same way other major industries in the United States do to protect their customers. The recommendation comes from two Johns Hopkins physicians and patient safety experts in a commentary published online April 29 in The Journal of the American Medical Association. In addition, the experts say, medical institutions should take a cue from other high-risk industries, like airlines, railways and nuclear power plants, and mandate that doctors be tested for drug or alcohol ...

Spinal 'spacer' procedure has fewer complications, but higher risk of repeat surgery

2013-05-07
Philadelphia, Pa. (May 7, 2013) - Interspinous spacer implantation—a less-invasive alternative surgical option for spinal stenosis—has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. However, patients receiving interspinous spacers are more likely to require repeated back surgery, according to the report by Dr Ricard A. Deyo and colleagues of Oregon Health & Science University, Portland. They conclude, "Use of interspinous spacers poses ...

Another 'trophy' for the chemistry cabinet

2013-05-07
The search for cleaner, low temperature nuclear fuels has produced a shock result for a team of experts at The University of Nottingham. First they created a stable version of a 'trophy molecule' that has eluded scientists for decades. Now they have discovered that the bonding within this molecule is far different than expected. Remarkably their findings have shown that it behaves in much the same way as its counterparts in the well-known transitional metals such as chromium, molybdenum and tungsten. The research, done by PhD student David King, which could help in ...

New technique can help nanoparticles deliver drug treatments

2013-05-07
DETROIT — A Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system. Joshua Reineke, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences, examined how a biodegradable polymer particle called polylactic-co-glycolic acid (PLGA) breaks down in live tissue. He believes the potential impact of his work is broad, as nanoparticles increasingly have been developed as carriers of drug treatments for numerous diseases ...

AGU journal highlights -- May 7, 2013

2013-05-07
The following highlights summarize research papers that have been recently published in Journal of Geophysical Research-Solid Earth (JGR-B), Journal of Geophysical Research-Oceans (JGR-C), Journal of Geophysical Research-Earth Surface (JGR-F) and Tectonics. In this release: Graphite lubricates fault zones Sediment processes can be significant source of ambient noise Evolution of the Qin Mountains as part of the supercontinent Rodinia Studying how flocculation affects acoustic reflection How do braided river dynamics affect sediment storage? Charting the ...

Restless legs syndrome, insomnia and brain chemistry: A tangled mystery solved?

2013-05-07
Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication. Neurologists have long believed RLS is related to a dysfunction in the way the brain uses the neurotransmitter dopamine, a chemical used by brain cells to communicate and produce smooth, purposeful muscle activity and movement. Disruption of these neurochemical signals, characteristic of Parkinson's ...

Older adults' memory lapses linked to problems processing everyday events

2013-05-07
Some memory problems common to older adults may stem from an inability to segment daily life into discrete experiences, according to a new study published in Psychological Science, a journal of the Association for Psychological Science. The study suggests that problems processing everyday events may be the result of age-related atrophy to a part of the brain called the medial temporal lobe (MTL). "When you think back on what you did yesterday, you don't just press 'play' and watch a continuous stream of 24 hours," says psychological scientist Heather Bailey of Washington ...

LAST 30 PRESS RELEASES:

Shedding light on materials in the physical, biological sciences

Study finds emotional tweets by politicians don’t always win followers and can backfire with diverse audiences

Paul “Bear” Bryant Awards announce 2025 Coach of the Year Award watch list

$3 million National Institute on Aging grant will provide much-needed support to underserved dementia caregivers

Study links obesity-driven fatty acids to breast cancer, warns against high-fat diets like keto

Did lead limit brain and language development in Neanderthals and other extinct hominids?

New study reveals alarming mental health and substance use disparities among LGBTQ+ youth

U.K. food insecurity is associated with mental health conditions

At least eight bat species commute or forage over pig farms in Northern Italy

Ancient teeth reveal mammalian responses to climate change in Southeast Asia

Targeting young adults beginning university may be especially effective for encouraging pro-environmental behaviors

This robotic skin allows tiny robots to navigate complex, fragile environments

‘Metabots’ shapeshift from flat sheets into hundreds of structures

Starting university boosts recycling and greener travel, a University of Bath study finds

How cilia choreograph their “Mexican wave”, enabling marine creatures to swim

Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's

Ancient lead exposure shaped evolution of human brain

How the uplift of East Africa shaped its ecosystems: Climate model simulations reveal Miocene landscape transformation

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

Research alert: Bacterial chatter slows wound healing

American Society of Anesthesiologists names Patrick Giam, M.D., FASA, new president

High-entropy alloy nanozyme ROS biocatalyst treating tendinopathy via up-regulation of PGAM5/FUNDC1/GPX4 pathway

SwRI’s Dr. Pablo Bueno named AIAA Associate Fellow

Astronomers detect radio signals from a black hole tearing apart a star – outside a galactic center

Locking carbon in trees and soils could help ‘stabilize climate for centuries’ – but only if combined with underground storage

New research shows a tiny, regenerative worm could change our understanding of healing

Australia’s rainforests first to switch from carbon sink to source

First-trimester mRNA COVID-19 vaccination and risk of major congenital anomalies

Glucose-lowering medication classes and cardiovascular outcomes in patients with type 2 diabetes

Rising seas and sinking cities signal a coastal crisis in China

[Press-News.org] New lung cancer guidelines recommends offering screening to high-risk individuals
Advances in treatment have major impact on short- and long-term outcomes